JWH-122

JWH-122 is a synthetic cannabinoid receptor agonist belonging to the naphthoylindole family. It was originally developed during scientific investigations into compounds that interact with the endocannabinoid system, particularly the cannabinoid CB1 and CB2 receptors.

It is structurally related to JWH-018 but contains an additional methyl group on the naphthalene ring. This structural modification is associated with strong cannabinoid-receptor activity in laboratory assays.

JWH-122 is not a naturally occurring cannabinoid and is not an approved medicine, dietary supplement, food ingredient or consumer product. Its legitimate applications are limited primarily to analytical chemistry, forensic toxicology, receptor research and authenticated reference-standard work.

Chemical information

• Common name: JWH-122
• Chemical class: Naphthoylindole synthetic cannabinoid
• Chemical name: (4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone
• Alternative description: 1-pentyl-3-(4-methyl-1-naphthoyl)indole
• Molecular formula: C₂₅H₂₅NO
• Molecular weight: Approximately 355.48 g/mol
• Commonly reported CAS number: 619294-47-2
• Intended context: Analytical, forensic and scientific laboratory research

Chemical identity should be confirmed through authenticated analytical documentation. Appearance, color or physical form alone cannot establish whether a sample is JWH-122.

Pharmacological characteristics

JWH-122 acts as an agonist at cannabinoid receptors. Published laboratory studies describe it as having high affinity for both CB1 and CB2 receptors.

CB1 receptors are found mainly in the central nervous system and participate in processes involving:

• Memory
• Coordination
• Perception
• Appetite
• Mood
• Pain signalling

CB2 receptors are found predominantly in immune and peripheral tissues, although they may also occur in certain areas of the nervous system.

JWH-122 has been reported to exhibit very strong receptor-binding activity in experimental systems. Exact affinity and potency values vary according to the assay, receptor preparation, species and laboratory method.

Synthetic cannabinoid receptor agonists may activate cannabinoid receptors more strongly or more completely than delta-9-tetrahydrocannabinol. Their biological effects may therefore be more intense and less predictable than those associated with conventional cannabis.

Research applications

Authenticated JWH-122 reference material may be used in controlled laboratory settings for:

• Cannabinoid receptor-binding studies
• Endocannabinoid-system research
• Analytical method development
• Forensic toxicology
• Metabolite identification
• Mass-spectrometry method validation
• Chromatographic comparison
• Screening of unknown forensic samples
• Examination of seized materials
• Development of analytical reference standards

Forensic laboratories may compare an unknown sample with an authenticated JWH-122 reference standard using retention time, mass-spectral fragmentation and other analytical characteristics.

Analytical identification

Laboratory techniques that may be used to identify JWH-122 include:

• Gas chromatography–mass spectrometry
• Liquid chromatography–tandem mass spectrometry
• High-resolution mass spectrometry
• Nuclear magnetic resonance spectroscopy
• Infrared spectroscopy
• Chromatographic retention-time comparison

Reliable identification normally requires comparison with an authenticated reference standard and supporting analytical data.

A properly documented research standard may include:

• Certificate of Analysis
• Batch or lot number
• Purity or assay result
• Chromatographic data
• Mass-spectral information
• Nuclear magnetic resonance data
• Date of analysis
• Storage recommendations
• Quality-control authorization

The batch number on the supplied container should match the batch number shown on the Certificate of Analysis.

Metabolism

JWH-122 undergoes extensive oxidative metabolism, as is typical of many synthetic cannabinoid receptor agonists.

Reported or proposed metabolic pathways include:

• Hydroxylation of the N-pentyl side chain
• Oxidation of hydroxylated side-chain metabolites
• Formation of carboxylic-acid metabolites
• Hydroxylation of the methyl-substituted naphthalene group
• Aromatic hydroxylation
• N-dealkylation
• Conjugation, particularly glucuronidation

The unchanged parent compound may be present for a shorter period than some of its metabolites. Forensic toxicology laboratories may therefore target hydroxylated, oxidized or conjugated metabolites in addition to JWH-122 itself.

The exact metabolic profile depends on factors such as:

• Biological system
• Sample type
• Time of collection
• Analytical method
• Instrument sensitivity
• Sample-preparation procedure

Toxicology and safety concerns

JWH-122 has not been adequately evaluated for human safety and is not approved for therapeutic, diagnostic, dietary or recreational use.

Synthetic cannabinoid receptor agonists as a broader class have been associated with serious adverse reactions, including:

• Rapid heart rate
• Elevated blood pressure
• Severe anxiety
• Agitation
• Confusion
• Hallucinations
• Psychotic symptoms
• Vomiting
• Seizures
• Loss of consciousness

These effects are associated with the wider synthetic-cannabinoid class and should not all be interpreted as uniquely established effects of JWH-122. However, its high cannabinoid-receptor activity and limited human toxicology data mean accidental exposure should be treated seriously.

JWH-122 is not intended for human or veterinary consumption, self-experimentation, therapeutic administration or household use.

Laboratory handling

JWH-122 should be handled only by trained personnel in an appropriately equipped laboratory.

Suitable controls may include:

• Reviewing the applicable Safety Data Sheet
• Completing a documented risk assessment
• Wearing chemical-resistant gloves
• Using suitable eye protection
• Wearing protective laboratory clothing
• Avoiding inhalation, ingestion and skin contact
• Using appropriate local exhaust ventilation
• Preventing dust or aerosol formation
• Keeping containers securely closed
• Labelling all secondary containers
• Restricting access to authorized personnel
• Preventing cross-contamination
• Maintaining complete receipt and usage records

Personnel should wash thoroughly after handling and should not eat, drink or store food in chemical-handling areas.

Storage considerations

Storage requirements should follow the supplier’s authenticated Certificate of Analysis and Safety Data Sheet.

General laboratory principles include:

• Store in a tightly closed, clearly labelled container
• Protect from unauthorized access
• Avoid unnecessary exposure to heat, moisture and light
• Keep incompatible materials separated
• Record the date received and opened
• Monitor any specified refrigeration or freezing conditions
• Maintain accurate inventory records

Batch-specific documentation should take priority over general storage recommendations.

Quality verification

Before using JWH-122 in laboratory work, researchers should verify:

• Product identity
• Batch or lot number
• Purity or assay information
• Analytical method
• Certificate authenticity
• Storage requirements
• Container integrity
• Date of analysis
• Intended research purpose
• Legal authorization

A professional-looking package does not confirm chemical identity or purity. Verification should be based on analytical evidence and traceable documentation.

Legal status

JWH-122 is controlled or restricted in many jurisdictions. It may also fall under broad synthetic-cannabinoid, analogue or generic drug-control laws even where it is not individually named.

Research-use statement

JWH-122 is intended only for legitimate analytical, forensic and scientific research conducted by qualified professionals. It is not approved for human or veterinary consumption, therapeutic use, diagnostic application or household use.